TARDBP and amyotrophic lateral sclerosis: In this experiment, ICT reduced the TDP-43 level in TDP-43-transfected SH-SY5Y cells, improved mitochondrial function and resisted oxidative stress, which indicates that it is a potential TDP-43-targeting drug for ALS.